Related references
Note: Only part of the references are listed.Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma
Ayca Tan et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2011)
Biomarkers for prognosis and treatment selection in advanced bladder cancer patients
Yuanbin Ru et al.
CURRENT OPINION IN UROLOGY (2011)
Molecular and Immunohistologic Analyses Cannot Reliably Solve Diagnostic Variation of Flat Intraepithelial Lesions of the Urinary Bladder
Shin-ichi Murata et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold L-arginine as amino-peptidase N/CD13 inhibitors
Jiajia Mou et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis
John D. Andersen et al.
ELECTROPHORESIS (2010)
Serum and Tissue Profiling in Bladder Cancer Combining Protein and Tissue Arrays
Esteban Orenes-Pinero et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Analysis of Secreted Proteins for the Study of Bladder Cancer Cell Aggressiveness
Manousos Makridalds et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Multidimensional protein fractionation of blood proteins coupled to data-independent nanoLC-MS/MS analysis
Yishai Levin et al.
JOURNAL OF PROTEOMICS (2010)
The cancer cell secretome: A good source for discovering biomarkers?
Maria P. Pavlou et al.
JOURNAL OF PROTEOMICS (2010)
Secretome proteomics for discovery of cancer biomarkers
Manousos Makridakis et al.
JOURNAL OF PROTEOMICS (2010)
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis
Harald Mischak et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis
Muriel De Bock et al.
TALANTA (2010)
Considerations on implementing diagnostic markers into clinical decision making in bladder cancer
Yair Lotan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Searching for serum tumor markers for colorectal cancer using a 2-D DIGE approach
Yanlei Ma et al.
ELECTROPHORESIS (2009)
Transaldolase: From biochemistry to human disease
Anne K. Samland et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Loss of Profilin-1 Expression Enhances Breast Cancer Cell Motility by Ena/VASP Proteins
Yong Ho Bae et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Are Protease Inhibitors Required for Gel-Based Proteomics of Kidney and Urine?
Phattara-Orn Havanapan et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Chromosomal and proteome analysis of a new T24-based cell line model for aggressive blamdder cancer
Manousos Makridakis et al.
PROTEOMICS (2009)
Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7
Simon Staubach et al.
PROTEOMICS (2009)
Secretome-based proteomics reveals sulindac-modulated proteins released from colon cancer cells
Hong Ji et al.
PROTEOMICS CLINICAL APPLICATIONS (2009)
Profilin-1 Overexpression Restores Adherens Junctions in MDA-MB-231 Breast Cancer Cells in R-cadherin-dependent Manner
Li Zou et al.
CELL MOTILITY AND THE CYTOSKELETON (2009)
Identification of free phosphopeptides in different biological fluids by a mass spectrometry approach
Claudia Cirulli et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Phospho-proteomic approach to identify new targets of leucine deprivation in muscle cells
Jeremie Talvas et al.
ANALYTICAL BIOCHEMISTRY (2008)
Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species
Roopali Roy et al.
CLINICAL CANCER RESEARCH (2008)
Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis
Dominique de Seny et al.
CLINICAL CHEMISTRY (2008)
Urinary markers in bladder cancer
Olaf P. J. Vrooman et al.
EUROPEAN UROLOGY (2008)
The global burden of urinary bladder cancer
D. Maxwell Parkin
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2008)
The moonlighting enzyme CD13: old and new functions to target
Paola Mina-Osorio
TRENDS IN MOLECULAR MEDICINE (2008)
Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: Comparison to bone marrow mesenchymal stem cells
Maria G. Roubelakis et al.
STEM CELLS AND DEVELOPMENT (2007)
Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach
Esteban Orenes-Pinero et al.
JOURNAL OF PROTEOME RESEARCH (2007)
UTRN on chromosome 6q24 is mutated in multiple tumors
Y. Li et al.
ONCOGENE (2007)
Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis
Massimo Papale et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Toward a better analysis of secreted proteins: the example of the myeloid cells secretome
Mireille Chevallet et al.
PROTEOMICS (2007)
Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma
Jizu Yi et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinorna cell lines is involved in inhibition of cell proliferation and migration
Nan Wu et al.
PROTEOMICS (2006)
Mass spectrometric proteomics profiles of in vivo tumor secretomes:: Capillary ultrafiltration sampling of regressive tumor masses
Chun-Ming Huang et al.
PROTEOMICS (2006)
Molecular markers in bladder cancer: A critical appraisal
Badrinath R. Konety
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
Silver staining of proteins in polyacrylamide gels
Mireille Chevallet et al.
NATURE PROTOCOLS (2006)
Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach
M Gronborg et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Neutrophil granule proteins as targets of leukemia-specific immune responses
J Barrett et al.
CURRENT OPINION IN HEMATOLOGY (2006)
Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry
RE Banks et al.
CLINICAL CHEMISTRY (2005)
Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis
G Candiano et al.
ELECTROPHORESIS (2004)
Tumor suppressor activity of profilin requires a functional actin binding site
N Wittenmayer et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Overexpression of profilin reduces the migration of invasive breast cancer cells
P Roy et al.
CELL MOTILITY AND THE CYTOSKELETON (2004)
The role of profilin complexes in cell motility and other cellular processes
W Witke
TRENDS IN CELL BIOLOGY (2004)
Apoptosis-induced proteinase 3 membrane expression is independent from degranulation
S Durant et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Current and prospective applications of metal ion-protein binding
EKM Ueda et al.
JOURNAL OF CHROMATOGRAPHY A (2003)
Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine
JE Nutt et al.
BJU INTERNATIONAL (2003)
Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: A role for inflammatory cells in tumor invasion and angiogenesis
P Shamamian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Perspectives of immobilized-metal affinity chromatography
V Gaberc-Porekar et al.
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS (2001)
Assessment of fibrin-fibrinogen degradation products (Accu-Dx) test in bladder cancer patients
M Topsakal et al.
EUROPEAN UROLOGY (2001)
Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1
J Janke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
